Fifty-year-old migraine treatment being phased out

+Print Archive

Fifty-year-old migraine treatment being phased out

Jonathan
Chilton Towle
headache
The migraine treatment Cafergot (AFT Pharmaceuticals) will no longer be approved for use in New Zealand from May next year. On 20 November, Medsaf